- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
November 14, 2019
Stem cell transplants continue to yield positive results in patients with multiple sclerosis and other autoimmune diseases, with the latest milestone emerging from Northwestern Medicine and Mayo Clinic.
October 24, 2019
Unfortunately, an established test for ovarian cancer, the CA125 test, is limited in its power and not recommended for general screening. Researchers in Ireland have come up with a potential improvement, a blood test that may be able to detect ovarian cancer one to two years earlier than current approaches.
October 17, 2019
One dose of one treatment to defeat multiple types of cancers? That’s the intriguing, if far-off, possibility suggested by a new development by UCLA scientists working with mice. The scientists focused on boosting production of “killer” immune cells that, though powerful, aren’t naturally prevalent enough in humans to make much of a difference for cancer patients.
October 10, 2019
Veteran health care informatics expert Benjamin Bielak recently joined iSpecimen as its first Chief Information Officer. He is the subject of our latest Q&A… The iSpecimen Marketplace is often compared to eBay or Amazon for clarity, but it’s certainly more complicated than that. What are the biggest technology challenges of an online marketplace not for […]
October 1, 2019
October officially kicks off Breast Cancer Awareness Month. Breast cancer is the most common cancer in women with about 245,000 new cases and 41,000 deaths each year.
September 19, 2019
Scientists have studied the human brain for millennia, but only recently have they been cultivating brains – well, “minibrains” – from scratch: Researchers at University of California San Diego have programmed human stem cells to grow the pea-sized organoids of brain tissue in the lab.
September 12, 2019
Liquid biopsies are among the most exciting areas of medical diagnostics. Although the technology is in its early stages, the hope is that liquid biopsies – through a simple draw of blood or other human biofluids – will detect cancer earlier and without the invasiveness of surgical or needle biopsies. The procedure could one day be simple and cost-effective enough to conduct in the doctor’s office or in the comfort of one’s own home, even before symptoms arise.